Which has the lower trailing P/E, BMRN or MOH?

BMRN has the lower trailing P/E: BMRN trades at 147.54 and MOH at 1021.32. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMRN or MOH?

Over the past five years, MOH grew revenue faster — BMRN at a 12.19% CAGR versus MOH at 13.56%.

Is BMRN or MOH more profitable?

BMRN runs the higher net margin — BMRN at 2.14% versus MOH at -0.02%.

How have BMRN and MOH total returns compared?

Over the past 10 years, BMRN delivered -4.98% and MOH delivered 13.01% annualized total return. Past performance doesn't predict future results.

BioMarin Pharmaceutical Inc. (BMRN) vs Molina Healthcare, Inc. (MOH)

A side-by-side comparison of BioMarin Pharmaceutical Inc. and Molina Healthcare, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BMRN

BioMarin Pharmaceutical Inc.

$11.12B

$57.54HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

MOH

Molina Healthcare, Inc.

$10.13B

$194.05HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BMRN vs MOH

growth of $100 · dividends reinvested · last 10y

BMRN -39.5% (-4.9%/yr)MOH +229.2% (+12.7%/yr)MOH compounded faster over this window

Log scale — wide-divergence pair

BMRN MOH

BMRN vs MOH: by the numbers

•BMRN is the larger company ($11.12B vs $10.13B market cap).
•BMRN trades at the lower trailing earnings multiple (147.54 vs 1021.32 P/E), one valuation lens rather than an overall verdict.
•BMRN is profitable (2.14% net margin) while MOH runs a net loss (-0.02%).
•MOH grew revenue faster over the past five years (13.56% vs 12.19% CAGR).

Metrics side by side

Valuation

Metric	BMRN	MOH
P/E ratio	147.54	1021.32
P/S ratio	3.26	0.23
P/B ratio	1.76	2.43
EV / EBITDA	33.90	19.61
FCF yield	6.59%	2.66%

Profitability

Metric	BMRN	MOH
Gross margin	75.55%	13.07%
Operating margin	16.56%	0.66%
Net margin	2.14%	-0.02%
ROE	1.15%	-0.17%
ROIC	1.40%	3.56%

Growth (annualized)

Metric	BMRN	MOH
Revenue CAGR (5Y)	12.19%	13.56%
EPS CAGR (5Y)	-17.46%	-4.78%
FCF CAGR (5Y)	33.84%	-33.98%
Total return CAGR (5Y)	-5.59%	-6.35%

Frequently asked

Which has the lower trailing P/E, BMRN or MOH?: BMRN has the lower trailing P/E: BMRN trades at 147.54 and MOH at 1021.32. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMRN or MOH?: Over the past five years, MOH grew revenue faster — BMRN at a 12.19% CAGR versus MOH at 13.56%.
Is BMRN or MOH more profitable?: BMRN runs the higher net margin — BMRN at 2.14% versus MOH at -0.02%.
How have BMRN and MOH total returns compared?: Over the past 10 years, BMRN delivered -4.98% and MOH delivered 13.01% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMRN analysis Full MOH analysis Interactive comparison tool

Dig into the metrics

BioMarin Pharmaceutical P/E ratio Molina Healthcare P/E ratio BioMarin Pharmaceutical ROE Molina Healthcare ROE BioMarin Pharmaceutical operating margin Molina Healthcare operating margin BioMarin Pharmaceutical revenue growth Molina Healthcare revenue growth BioMarin Pharmaceutical free cash flow Molina Healthcare free cash flow

BioMarin Pharmaceutical & Molina Healthcare appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.